LIFECORE BIOMEDICAL, INC. Deferred Tax Liabilities, Net, Noncurrent
LIFECORE BIOMEDICAL, INC. (LFCR) had Deferred Tax Liabilities, Net, Noncurrent of $19.39 million as of 2019-05-26, per its 10-K filed 2019-08-01.
Discontinued › Notes › Income Taxes
us-gaap:DeferredTaxLiabilitiesNoncurrent · last filed 2019-08-01
- 2019-05-26: Deferred Tax Liabilities, Net, Noncurrent $19.39M.
- 2019-02-24: Deferred Tax Liabilities, Net, Noncurrent $17.39M.
- 2018-11-25: Deferred Tax Liabilities, Net, Noncurrent $17.71M.
- 2018-08-26: Deferred Tax Liabilities, Net, Noncurrent $17.39M.
| Period end | Deferred Tax Liabilities, Net, Noncurrent | Deferred Tax Liabilities, Net, Noncurrent as first filed |
|---|---|---|
| 2019-05-26 | $19.39M 10-K · filed 2019-08-01 | |
| 2019-02-24 | $17.39M 10-Q · filed 2019-04-04 | |
| 2018-11-25 | $17.71M 10-Q · filed 2019-01-07 | |
| 2018-08-26 | $17.39M 10-Q · filed 2018-10-05 | |
| 2018-05-27 | $17.48M 10-K · filed 2019-08-01 | |
| 2018-02-25 | $15.82M 10-Q · filed 2018-04-05 | |
| 2017-11-26 | $26.03M 10-Q · filed 2018-01-05 | |
| 2017-08-27 | $25.67M 10-Q · filed 2017-09-28 | |
| 2017-05-28 | $24.58M 10-K · filed 2018-08-09 | |
| 2017-02-26 | $25.51M 10-Q · filed 2017-04-07 | |
| 2016-11-27 | $24.33M 10-Q · filed 2017-01-05 | |
| 2016-08-28 | $23.55M 10-Q · filed 2016-09-29 | |
| 2016-05-29 | $22.44M 10-K/A · filed 2018-03-15 | |
| 2016-02-28 | $21.67M 10-Q · filed 2016-03-30 | |
| 2015-11-29 | $35.46M 10-Q · filed 2016-01-07 | |
| 2015-08-30 | $34.78M 10-Q · filed 2015-10-01 | |
| 2015-05-31 | $34.34M 10-K · filed 2016-08-01 | |
| 2015-03-01 | $34.38M 10-Q · filed 2015-04-02 | |
| 2014-11-30 | $31.48M 10-Q · filed 2015-01-09 | |
| 2014-08-31 | $30.58M 10-Q · filed 2014-10-08 | |
| 2014-05-25 | $30.13M 10-K · filed 2015-07-31 | |
| 2014-02-23 | $29.53M 10-Q · filed 2014-03-28 | |
| 2013-11-24 | $28.32M 10-Q · filed 2014-01-03 | |
| 2013-08-25 | $26.78M 10-Q · filed 2013-09-26 | |
| 2013-05-26 | $24.05M 10-K · filed 2014-08-01 | |
| 2013-02-24 | $22.28M 10-Q · filed 2013-04-04 | |
| 2012-11-25 | $21.08M 10-Q · filed 2013-01-04 | |
| 2012-08-26 | $19.98M 10-Q/A · filed 2013-01-02 | $18.91M 10-Q · filed 2012-10-03 |
| 2012-05-27 | $18.04M 10-K · filed 2013-08-07 | |
| 2012-02-26 | $12.63M 10-Q · filed 2012-03-28 | |
| 2011-11-27 | $12.01M 10-Q · filed 2012-01-05 | |
| 2011-08-28 | $11.47M 10-Q · filed 2011-10-05 | |
| 2011-05-29 | $11.34M 10-K · filed 2012-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |